Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bibby

Showing results (151-160 of 204) with videos related to

Pageof 21
Sort By:
Journal of Reproduction and Fertility|June 24, 2000
Role of O6-alkylguanine-DNA alkyltransferase in the resistance of mouse spermatogenic cells to O6-alkylating agentsM J Thompson, S Abdul-Rahman, T G Baker, et al.
Breast Cancer Research and Treatment|January 1, 1994
Antineoplastic activity of alkylphosphocholines (APC) in human breast carcinomas in vivo and in vitro; use of liposomesI Fichtner, R Zeisig, H Naundorf, et al.
Anti-Cancer Drug Design|April 1, 1993
Nucleoside analogues. 13. The effect on anti-tumour activity of varying the uracil 5-substituent and the point of attachment (N1 or N3) of the uracil moiety in seco-nucleoside nitrosoureasM C Bibby, J A Double, J E McCormick, et al.
Anticancer Research|September 15, 2005
Development of a modified hollow fibre assay for studying agents targeting the tumour neovasculatureS D Shnyder, J Hasan, P A Cooper, et al.
European Journal of Medicinal Chemistry|February 7, 2006
Polar, functionalized guanine-O6 derivatives resistant to repair by O6-alkylguanine-DNA alkyltransferase: implications for the design of DNA-modifying drugsDimitrios Pletsas, Richard T Wheelhouse, Vassiliki Pletsa, et al.
Archiv Der Pharmazie|July 1, 1997
Synthesis and antitumour activity of new derivatives of flavone-8-acetic acid (FAA). Part 2: Ring-substituted derivativesR A Aitken, M C Bibby, J A Double, et al.
British Journal of Cancer|June 23, 2000
Enhancement of chemotherapy and radiotherapy of murine tumours by AQ4N, a bioreductively activated anti-tumour agentL H Patterson, S R McKeown, K Ruparelia, et al.
Anti-Cancer Drug Design|February 1, 1992
Synthesis and cytotoxicity of shikimate analogues. Structure:activity studies based on 1-crotonyloxymethyl-3R,4R,5R-trihydroxycyclohex-2-enoneO Aghil, M C Bibby, S J Carrington, et al.
Cancer Research|December 16, 1998
Angiogenesis in the hollow fiber tumor model influences drug delivery to tumor cells: implications for anticancer drug screening programsR M Phillips, J Pearce, P M Loadman, et al.
Journal of Natural Products|September 25, 2004
In-vitro cytotoxic activities of the major bromophenols of the red alga Polysiphonia lanosa and some novel synthetic isomersNagwa A Shoeib, Michael C Bibby, Gerald Blunden, et al.
Pageof 21

Showing results (151-160 of 204) with videos related to

Sort By:
Pageof 21
Journal of Reproduction and Fertility|June 24, 2000
Role of O6-alkylguanine-DNA alkyltransferase in the resistance of mouse spermatogenic cells to O6-alkylating agentsM J Thompson, S Abdul-Rahman, T G Baker, et al.
Breast Cancer Research and Treatment|January 1, 1994
Antineoplastic activity of alkylphosphocholines (APC) in human breast carcinomas in vivo and in vitro; use of liposomesI Fichtner, R Zeisig, H Naundorf, et al.
Anti-Cancer Drug Design|April 1, 1993
Nucleoside analogues. 13. The effect on anti-tumour activity of varying the uracil 5-substituent and the point of attachment (N1 or N3) of the uracil moiety in seco-nucleoside nitrosoureasM C Bibby, J A Double, J E McCormick, et al.
Anticancer Research|September 15, 2005
Development of a modified hollow fibre assay for studying agents targeting the tumour neovasculatureS D Shnyder, J Hasan, P A Cooper, et al.
European Journal of Medicinal Chemistry|February 7, 2006
Polar, functionalized guanine-O6 derivatives resistant to repair by O6-alkylguanine-DNA alkyltransferase: implications for the design of DNA-modifying drugsDimitrios Pletsas, Richard T Wheelhouse, Vassiliki Pletsa, et al.
Archiv Der Pharmazie|July 1, 1997
Synthesis and antitumour activity of new derivatives of flavone-8-acetic acid (FAA). Part 2: Ring-substituted derivativesR A Aitken, M C Bibby, J A Double, et al.
British Journal of Cancer|June 23, 2000
Enhancement of chemotherapy and radiotherapy of murine tumours by AQ4N, a bioreductively activated anti-tumour agentL H Patterson, S R McKeown, K Ruparelia, et al.
Anti-Cancer Drug Design|February 1, 1992
Synthesis and cytotoxicity of shikimate analogues. Structure:activity studies based on 1-crotonyloxymethyl-3R,4R,5R-trihydroxycyclohex-2-enoneO Aghil, M C Bibby, S J Carrington, et al.
Cancer Research|December 16, 1998
Angiogenesis in the hollow fiber tumor model influences drug delivery to tumor cells: implications for anticancer drug screening programsR M Phillips, J Pearce, P M Loadman, et al.
Journal of Natural Products|September 25, 2004
In-vitro cytotoxic activities of the major bromophenols of the red alga Polysiphonia lanosa and some novel synthetic isomersNagwa A Shoeib, Michael C Bibby, Gerald Blunden, et al.
Pageof 21